Medtronic Complete SE
This article was originally published in The Gray Sheet
Executive Summary
Self-expanding stent gains FDA market go-ahead for treatment of peripheral arterial disease in the iliac arteries, the firm announces April 21. The device features a "dual-deployment" delivery system with a "unique triaxial design," the firm explains. Complete SE, which gained 510(k) clearance for biliary use in 2007, is also being studied in a clinical trial for treatment of superficial femoral artery stenoses, Medtronic notes. The firm is also studying its balloon-expandable Assurant Cobalt stent in iliac artery disease